Abstract

BackgroundLymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers. We aimed to develop a scoring system for stratifying LVI risk in patients with breast cancer.MethodsA total of 301 consecutive patients (mean age, 49.8 ± 11.0 years; range, 29–86 years) with breast cancer confirmed by pathological reports were retrospectively evaluated at the authors’ institution between June 2015 and October 2018. All patients underwent contrast-enhanced Magnetic Resonance Imaging (MRI) examinations before surgery. MRI findings and histopathologic characteristics of tumors were collected for analysis. Breast LVI was confirmed by postoperative pathology. We used a stepwise logistic regression to select variables and two cut-points were determined to create a three-tier risk-stratification scoring system. The patients were classified as having low, moderate and high probability of LVI. The area under the receiver operating characteristic curve (AUC) was used to evaluate the discrimination ability of the scoring system.ResultsTumor margins, lobulation sign, diffusion-weighted imaging appearance, MRI-reported axillary lymph node metastasis, time to signal intensity curve pattern, and HER-2 were selected as predictors for LVI in the point-based scoring system. Patients were considered at low risk if the score was < 3.5, moderate risk if the score was 3.5 to 6.0, and high risk if the score was ≥6.0. LVI risk was segmented from 0 to 100.0% and was positively associated with an increase in risk scores. The AUC of the scoring system was 0.824 (95% confidence interval [CI]: 0.776--0.872).ConclusionThis study shows that a simple and reliable score-based risk-stratification system can be practically used in stratifying the risk of LVI in breast cancer.

Highlights

  • Lymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers

  • Development of point-based scoring system for predicting LVI By multivariate logistic regression analysis, seven variables were significantly related to LVI and were assigned scores for the final prediction rule: margins (ill-defined [1.0 points], lobulation sign, diffusion-weighted imaging (DWI) appearance, to signal intensity curve (TIC) pattern, MRIreported axillary lymph node metastasis (ALNM), HER2 (+ [0 points], 2+ [1.0 points], 3+ [1.5 points]) (Table 3)

  • If patients had < 3.5 points the probability of LVI was low with 5.3%

Read more

Summary

Introduction

Lymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers. We aimed to develop a scoring system for stratifying LVI risk in patients with breast cancer. The first study on the prognostic significance of peritumoral lymphovascular invasion (LVI) in breast cancer was reported in 1964 [1], and not a few subsequent studies have reported the association between LVI and clinical outcomes of breast cancer. Accumulating evidence has showed that LVI has an Recently, a preliminary study used nomogram to predict the presence of LVI based on multiparametric magnetic resonance imaging (MRI) and pathological reports [6]. This study aimed to develop a scoring system for stratifying the LVI risk of breast cancer based on pretreatment clinical, MRI and pathologic parameters

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call